The cost of carboplatin and cisplatin — lifesaving chemotherapy medications — have skyrocketed, forcing some hospitals to pay five to 10 times more than before the drugs were reported in short supply in the United States, according to an Aug. 17 NBC News report.
Read the full post on Becker's Hospital Review - Healthcare News
